期刊文献+

辅酶Q10治疗蒽环类药物致心脏毒性的疗效 被引量:1

Coenzyme Q10(CoQ10) reduce the heart toxicity caused by anthracycline-based chemotherapy drugs
在线阅读 下载PDF
导出
摘要 目的:研究辅酶Q10(CoQ10)对使用蒽环类化疗药物致心脏毒性的保护作用,并探讨可能的机理。方法:60例肿瘤患者随机分为治疗组(30例)和对照组(30例),化疗同时分别予CoQ10及大剂量维生素E治疗,治疗前后行心电图、心肌酶检查。结果:化疗后CoQ10组心电图和血清心肌酶学指标均优于对照组(P<0.05)。结论:CoQ10对蒽环类化疗药物所致心脏毒性有保护作用。 Objective:To study the protective effect of CoQ10 on the cardiovascular toxicity induced by anthracycline,and investigate the possible mechanisms.Methods:Sixty tumor patients were randomly divided into treatment group(30 cases) and control group(30 cases).Receiving chemotherapy,at the same time,CoQ10 and a large dose of vitamin E were given in two groups.Electrocardiography and cardiac enzymes were examined before and after treatment.Results: ECG and myocardial enzyme were all improved significantly in the treatment group,and the changes were superior to those of the control group(P0 05).Conclusion:CoQ10 had protective effects on the cardiovascular toxicity induced by anthracycline.
出处 《现代肿瘤医学》 CAS 2012年第10期2159-2161,共3页 Journal of Modern Oncology
关键词 辅酶Q10 蒽环类药物 心脏毒性 Coenzyme Q10(CoQ10) cardio toxity anthacycline
作者简介 孙玉书(1978-),女,蒙古族,辽宁人,硕士,主治医师,主要从事肿瘤临床工作。E—mail:jsgaopeiwen@163.com.cn
  • 相关文献

参考文献8

二级参考文献81

  • 1张明岩,安晶红,柴淼,潘宇,袁国明.阿霉素在临床应用中心脏毒性的研究进展[J].哈尔滨医药,2008,28(5):55-56. 被引量:6
  • 2陈冀莹.心肌损伤标志物的应用及临床意义[J].国外医学(放射医学核医学分册),2004,28(5):216-219. 被引量:17
  • 3Germanakis I, Kalmanti M, Parthenakis F, et al. Correlation of plasma N-terminal pro-brain natriuretic peptide level with left ventricle mass in children treated with anthracyclines[ J]. Int J Cardiol,2006,108:212 -215.
  • 4Malty M, Espie M, Llombart A, et al. Muhicenter randomized Phase Ⅲ study of the cardioprotective effect of dexrazoxane in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy[ J]. Ann Onco1,2006 ,17 :614 - 622.
  • 5Sterba M, Popelova O, Simunek T, et al. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH) [ J ]. Toxicology ,2007,253 ( 3 ) : 150 - 166.
  • 6Kaiserva H, Simunek T, van der Vijgh W J, et al. Flavonoids as protectors against doxorubicin cardiotoxicity : role of iron chelation, an-tioxidant activity and inhibition of carbonyl reductase [ J ]. Biochim Biophys Acta,2007,1772 : 1065 - 1074.
  • 7Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the eardiotoxic mechanisms to management[ J], Prag Cardiovase Dis,2007,49 (5) :330 - 352.
  • 8Saad SY, Najjar TA, Arafah MM. Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardimyopathy in rats [ J ]. Basic Clin Pharmacol Toxico1,2006,99 (6) :412 - 417.
  • 9Hou XW, Son J, Wang Y, et al. Granulocyte colony-stimulating factor reduces cardiomyocyte apoptosis and improves cardiac function in adriamycin-induced cardiomyopathy in rats[ J]. Cardiovasc Drugs Ther, 2006,20 : 85 - 91.
  • 10Li K, Sung RY, Huang WZ, et al. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin [ J ]. Circulation ,2006,113 ( 18 ) :2211 - 2220.

共引文献97

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部